*Corresponding Author:
Yongchao Zhang
Department of Cardiology, First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi Province 710061, China
E-mail: wangkatg345482@163.com
Date of Received 05 November 2022
Date of Revision 14 October 2023
Date of Acceptance 07 May 2024
Indian J Pharm Sci 2024;86(3):1156-1160  

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms

Abstract

To explore the role of steroid saponins from the flowers of Cestrum noctumum Linn on lung cancer cell epithelial-mesenchymal transition and the molecular mechanisms. Lung cancer cells (A549) were divided into normal control group, steroid saponins from the flowers of Cestrum noctumum Linn group, microRNA-181a-5p group, microRNA-control group, 40 μg/ml steroid saponins from the flowers of Cestrum noctumum Linn+anti-microRNA-181a-5p group and 40 μg/ml steroid saponins from the flowers of Cestrum noctumum Linn+anti-microRNA-control group. Reverse transcription-quantitative polymerase chain reaction was utilized for detecting ribonucleic acid expression. 3-(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyl tetrazolium bromide, clone formation test and transwell assays were performed to analyze A549 lung cancer cell process. Western blot was conducted for detecting protein expression. Steroid saponins from the flowers of Cestrum noctumum Linn treatment inhibited A549 lung cancer cell proliferation and motility, accompanied by decrease of matrix metalloproteinase 2, matrix metalloproteinase 9, N-cadherin, vimentin as well as beta-catenin expression and increases of E-cadherin and microRNA-181a-5p expression. At the same time, elevating microRNA-181a-5p reduced the number of cell clones, repressed cell ability to motility and decreased matrix metalloproteinase 2, matrix metalloproteinase 9, N-Cadherin and vimentin expressions, whereas elevating microRNA-181a-5p increased E-cadherin expression. Inhibiting microRNA-181a-5p expression can rescue steroid saponins from the flowers of Cestrum noctumum Linn induced effects on epithelial-mesenchymal transition and beta-catenin expression in A549 cells. Steroid saponins from the flowers of Cestrum noctumum Linn inhibited epithelial-mesenchymal transition of lung cancer cells through regulation of microRNA-181a-5p/Wnt/β-catenin pathway.

Keywords

Myocardial ischemia, microRNA-210, adenovirus EIB interacting protein 3, apoptosis, autophagy signal

Cardiovascular Disease (CVD) is the main cause of human death worldwide, and ischemic injury is an important factor leading to CVD[1]. It has been reported that timely reperfusion is beneficial to promote the recovery of hypoxic tissue, but the longer the hypoxia time is, the more serious the injured tissue injury is, which is called ischemiareperfusion injury[2]. Ischemia-reperfusion injury is closely related to physiological and pathological processes such as apoptosis, autophagy and necrosis, in which autophagy has a certain regulatory function in CVD[3]. Therefore, exploring the possible regulatory factors of autophagy has been the focus in the field of cytology. microRNA-210 (miR-210), a member of the miRNAs family, has become a recognized hypoxia related miRNA and can play a stable biological effect in many cell lines[4]. MiR-210 can control many genes, but only some genes can confirm its regulatory function in CVD[5]. Adenovirus EIB Interacting Protein 3 (BNIP3) is a hypoxiaregulated protein with diverse functions in the process of apoptosis[6]. Clinical studies have shown that miR-210 can participate in a variety of cellular processes by regulating B-Cell Lymphoma 2 (Bcl- 2)/BNIP3, which can affect cell autophagy. Other studies have confirmed that BNIP3 can be highly expressed in CVD, and blocking the expression of this gene can alleviate the degree of myocardial damage, but its significance in the diagnosis and treatment of CVD is not clear[7,8]. Therefore, in this study, the rat cardiomyocyte H9c2 was used to establish the model of myocardial ischemia, and this study aimed to explore the mechanism of miR- 210's cytoprotective effect by inhibiting BNIP3 and then blocking apoptosis and autophagy signal pathway. Rat H9c2 cells were purchased from Wuxi Xinrun Biotechnology Co., Ltd., and all cells were incubated in high-glucose Dulbecco’s Modified Eagle Medium (DMEM) (containing 10 % Fetal Bovine Serum (FBS)) and incubated in Carbon dioxide (CO2) incubator (37°). After a series of operations such as resuscitation, passage and cryopreservation, they were cryopreserved. Rat H9c2 cells were randomly divided into blank control (group A), model (group B), miR-210 (group C) and miR-210 inhibition group (group D). Group B, C and D were cultured in hypoxia to establish myocardial ischemia model. After successful modeling, the group B did not do any treatment. Lentivirus transfection was used in group C and D to construct cells with high expression of miR-210 and low expression of miR- 210 inhibition. Western blotting was used to detect miR-210, BNIP3, autophagy related indexes (microtubule associated protein 1 Light Chain 3 (LC3B1), LC3B2), apoptosis related indexes (caspase-3), Bcl-2, Bcl-2-Associated protein X (BAX)) protein expression and LC3BI/LC3B2II ratio in H9c2 cells of rats in group A, B, C and D. The miR-210 and BNIP3 in each group were expressed by (x̄ ±s). T-test was used for comparison between the two groups, and multivariate analysis of variance was used for comparison between groups. All data in this study were analyzed by Statistical Package for the Social Sciences (SPSS) 19.0. p<0.05 was considered to be statistically significant and compared with the group A, ap<0.05 and compared with the group B, bp<0.05. The miR- 210 in the group B was reduced than the group A, while the BNIP3 protein in the group B was raised than the group A. The miR-210 in the group C was raised than the group B, while the BNIP3 protein was decreased than the group B (Table 1 and fig. 1). The LC3B1 and LC3B2 protein and the ratio of LC3BI/LC3B2II in the group B were raised than the group A, while these in group C were reduced than the group B, and these in group D were increased than the group B (Table 2 and fig. 2). The caspase-3 and BAX protein in the group B was raised than the group A, while the Bcl-2 protein was reduced than the group A. The protein caspase-3 and Bax in the group C was decreased than the group B, while the Bcl-2 protein was increased than the group B (Table 3 and fig. 3). MiR-210 has become the focus of current researchers, and the research on it is very extensive. Clinical studies have shown that Hypoxia- Inducible Factor 1-Alpha (HIF-1α) can downregulate the miR-210 in knockout mice. Through co-immunoprecipitation reaction, other scholars found that HIF-1α usually binds to the miR-210 promoter under hypoxia compared with cells with normal oxygen content[9]. Animal experiments have confirmed that some drugs, such as Huoxue Anxin recipe, can induce the up-regulation of miR-210 expression[10]. In addition, serum reactive factor can stimulate many miRNAs activation, which is an exogenous activator. MiR-210 can regulate the hypoxia response of cardiovascular system through apoptosis, autophagy, migration and other biological aspects, and play its protective role. The most common role of this gene is to block apoptosis and alleviate cell survival. A number of reports have shown that the increase of its expression level can significantly reduce the rate of apoptosis[11]. Other scholars have found that in hydrogen peroxide moral mouse cardiomyocyte model, miR-210 can block the expression of apoptosis-promoting gene caspase-8, and finally inhibit apoptosis[12]. Cells stimulated by hypoxia are mainly apoptotic, and the up-regulation of BNIP3 expression can promote apoptosis[13]. Some scholars found that hypertrophic HL-1 cardiomyocytes were used to establish hypoxia model, and found that BNIP3 accumulated obviously. In addition, it can be used as a key protein of hypoxic cell necrosis and apoptosis. Other studies found that mutants with Bcl-2 gene mutations could not bind to BNIP3, accompanied by the decrease of anti-apoptotic effect of Bcl-2. It is suggested that BNIP3 can bind to anti-apoptotic proteins to play a protective role[14]. Autophagy is a process involving the degradation of longevity proteins and organelles. Some scholars have established a malignant glioma model by ceramide stimulation. The results show that BNIP3 can play an autophagy control function in autophagy death[15]. Another study found that BINP3 can induce autophagy and protect hypertrophic HL-1 cardiomyocytes from ischemia-reperfusion injury[16]. Here, the ischemia model of cardiomyocytes was established by anoxic culture, and the high expression of miR-210 and low expression of miR-210 inhibition were constructed by lentivirus transfection, and the negative control group and group A were set up to explore whether miR-210 can protect cardiomyocytes by inhibiting BNIP3 from apoptosis and autophagy. First of all, we detected the expression of miR-210 and BNIP3 protein in the myocardial ischemia model. The miR-210 in the group B was reduced than the group A, while the BNIP3 protein in the group B was raised than the group A. The miR-210 in the group C was increased than the group B, while the BNIP3 protein was reduced than the group B. It is suggested that miR-210 and BNIP3 are involved in the whole process of cardiomyocyte ischemia, and the expression of miR-210 is low and BNIP3 is high in this disease. In addition, we further detected the expression level of autophagy-related proteins in each group. The LC3B1 and LC3B2 protein and the ratio of LC3BI/LC3B2II in the group B were raised than the group A. The LC3B1 and LC3B2 protein and the ratio of LC3BI/ LC3B2II in group C were reduced than the group B, while these in group D were increased than the group B. It is suggested that up-regulation of miR- 210 can block the LC3BI and LC3B2II, while down-regulation of miR-210 can prick them. Finally, we detected whether miR-210 can participate in the regulation of BNIP3 and then control apoptosis. The results showed that the caspase-3 and BAX protein in the group B was increased than the group A, while the Bcl-2 protein was decreased than the group A. The caspase-3 and Bax in the group C was reduced than the group B, while the Bcl-2 protein was raised than the group B. It is suggested that up-regulating of miR- 210 can inhibit the BNIP3 and further inhibit apoptosis, which has the function of cell protection. To sum up, the expression level of miR-210 decreased and the expression of BNIP3 increased in the model of cardiomyocyte ischemia. MiR-210 plays a protective role in the process of cardiomyocyte ischemia, which may be achieved by inhibiting BNIP3 and blocking apoptosis and autophagy signal pathway.

Group miR-210 BNIP3 protein
A 1.00 1.00
B 0.44±0.02a 1.78±0.19a
C 3.19±0.83b 0.73±0.02b
D 0.48±0.03 1.84±0.25

Table 1: Comparison of miR-210 and BNIP3 in Expression in Different Groups (x̄±s)

Group LC3BI/LC3BII
A 1.00
B 2.00±0.01
C 0.66±0.04a
D 2.26±0.47ab

Table 2: Comparison of Expression Levels of Autophagy-Related Proteins (x̄±s)

Group Caspase-3 Bcl-2 BAX
A 1.05±0.07 1.02±0.05 1.04±0.08
B 2.51±0.15 0.59±0.02 2.67±0.31
C 0.54±0.09a 1.23±0.06ba 0.49±0.04a
D 2.86±0.23b 0.51±0.01b 2.88±0.38b

Table 3: Comparison of Expression Levels of Apoptosis-Related Proteins (x̄±s)

miR

Fig. 1: The miR-210 and BNIP3 expression in different groups
Equation

autophagy

Fig. 2: Comparison of expression levels of autophagy-related proteins

proteins

Fig. 3: Comparison of expression levels of apoptosis-related proteins
Equation

Conflict of interests:

The authors declared no conflict of interests.

References